Axsome Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -130.40M-187.13M-239.24M-287.22M
Depreciation and Depletion 0.00M0.02M0.04M0.05M0.04M0.02M0.08M0.26M0.46M0.53M
Share-based Compensation 0.38M0.80M2.03M2.07M1.75M6.12M14.76M20.80M37.73M62.62M85.22M
Gains from Sales and Divestitures 0.08M0.19M0.27M
Gains from Investment Securities 0.06M0.11M0.09M0.65M-2.79M0.03M1.79M0.18M6.62M8.46M8.44M
Non-cash Items 300.65M162.00M146.60M
Cash from Operations -4.60M-7.44M-21.28M-26.47M-30.05M-46.38M-78.46M-108.23M-116.51M-145.08M-128.41M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -2.65M0.04M0.07M0.47M0.38M0.65M0.79M1.08M4.14M6.38M6.39M
Amortization of Deferred Charges 0.14M0.01M0.05M0.35M
Depreciation & Amortization (CF) 0.00M0.02M0.04M0.05M0.04M0.02M0.08M0.26M0.46M0.53M
Change in Working Capital
Change in Receivables 37.70M57.12M47.18M
Change in Inventory 1.33M8.16M-0.74M
Change in Account Payables 0.60M1.13M2.19M-0.65M0.25M7.26M2.56M-0.35M25.46M2.07M31.32M
Change in Accured Expenses 0.03M0.70M2.08M-0.14M1.16M7.11M-2.24M0.58M43.92M36.45M56.06M
Investing Activities
Capital Expenditures 0.02M0.10M0.01M0.03M0.02M0.05M0.31M0.70M0.58M0.27M
Acquisitions 53.00M
Cash from Investing Activities -0.02M-0.10M-0.01M-0.03M-0.02M-0.05M-0.31M-53.70M-0.58M-0.27M
Financing Activities
Other financing activities 0.03M0.01M0.06M0.03M1.10M0.31M6.97M15.67M0.82M
Cash from Financing Activities 5.13M52.88M9.97M23.88M10.03M252.39M42.41M11.13M284.58M331.01M57.84M
Additional items
Change in Cash 0.53M45.42M-11.42M-2.60M-20.05M206.00M-36.09M-97.40M114.37M185.35M-70.84M
Beginning Cash Balance 0.02M0.04M
Free Cash Flow -4.60M-7.46M-21.39M-26.48M-30.09M-46.39M-78.50M-108.53M-117.21M-145.66M-128.68M
Net Cash Flow 0.53M45.42M-11.42M-2.60M-20.05M206.00M-36.09M-97.40M114.37M185.35M-70.84M